Triglyceride increase can predict lipodystrophy in HIV patients under highly active antiretroviral therapy
- 1 July 2002
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 16 (10) , 1434-1436
- https://doi.org/10.1097/00002030-200207050-00022
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort studyPublished by Elsevier ,2001
- Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment databaseAIDS, 2001
- Lipodystrophy, Metabolic Disorders, and Human Immunodeficiency Virus Infection: Aquitaine Cohort, France, 1999Clinical Infectious Diseases, 2000
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999